Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): No association with disease

被引:92
|
作者
Bottto, M
Theodoridis, E
Thompson, EM
Beynon, HLC
Briggs, D
Isenberg, DA
Walport, MJ
Davies, KA
机构
[1] HAMMERSMITH HOSP, RHEUMATOL UNIT, RPMS, DEPT MED, LONDON W12 0NN, ENGLAND
[2] HAMMERSMITH HOSP, RPMS, DEPT HISTOPATHOL, LONDON W12 0NN, ENGLAND
[3] UCL, BLOOMSBURY RHEUMATOL UNIT, DEPT MED, LONDON, ENGLAND
[4] UCL, DEPT IMMUNOL, LONDON, ENGLAND
来源
CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 1996年 / 104卷 / 02期
关键词
Fc receptor; systemic lupus erythematosus; polymorphism;
D O I
10.1046/j.1365-2249.1996.33740.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
An allotypic variant of Fc gamma RIIa, Fc gamma RIIa-HR (Fc gamma RIIa-R131), has been shown in vitro to reduce the capacity of phagocytic cells to bind and internalize IgG-containing immune complexes. Our aim was to determine whether this allotypic variant was associated with susceptibility to SLE and the development of lupus nephritis, as previous studies have suggested. Fc gamma RIIA genotype analysis was performed by amplification refractory mutation system-polymerase chain reaction (ARMS-PCR) in 215 Caucasoid, 70 Afro-Caribbean, and 46 Chinese patients with SLE, and in 259, 77, and 49 ethnically matched controls, respectively. Distribution of Fc gamma RIIa genotypes between the patients and ethnically matched controls was not significantly different in the three populations studied. No association between the Fc gamma RIIa-HR allotype and nephritis was found. Our results suggest that the Fc gamma RIIa-HR allotype is not a major factor predisposing to the development of SLE, or to lupus nephritis.
引用
收藏
页码:264 / 268
页数:5
相关论文
共 50 条
  • [11] Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
    Anders A. Bengtsson
    Helena Tyden
    Christian Lood
    Arthritis Research & Therapy, 22
  • [12] Neutrophil FcγRIIA availability is associated with disease activity in systemic lupus erythematosus
    Bengtsson, Anders A.
    Tyden, Helena
    Lood, Christian
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [13] Association of FcγRIIA-R/H131 polymorphism and systemic lupus erythematosus lupus nephritis risk: A meta-analysis
    Xu, Yuan
    Wei, Hui-Ting
    Zou, Jun-Ju
    Ma, Yue-Rong
    INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES, 2020, 23 (07) : 853 - 867
  • [14] FcγRlla polymorphism in systemic lupus erythematosus
    Tan, SY
    KIDNEY & BLOOD PRESSURE RESEARCH, 2000, 23 (02): : 138 - 142
  • [15] FcγRIIA, FcγRIIIA and FcγRIIIB polymorphisms in Spanish patients with systemic lupus erythematosus
    González-Escribano, MF
    Aguilar, F
    Sánchez-Román, J
    Núñez-Roldán, A
    EUROPEAN JOURNAL OF IMMUNOGENETICS, 2002, 29 (04): : 301 - 306
  • [16] APRIL polymorphism and systemic lupus erythematosus (SLE) susceptibility
    Lee, Y. H.
    Ota, F.
    Kim-Howard, X.
    Kaufman, K. M.
    Nath, S. K.
    RHEUMATOLOGY, 2007, 46 (08) : 1274 - 1276
  • [17] Mannose binding lectin and FcγRIIa (CD32) polymorphism in Spanish systemic lupus erythematosus patients
    Villarreal, J
    Crosdale, D
    Ollier, W
    Hajeer, A
    Thomson, W
    Ordi, J
    Balada, E
    Villardell, M
    Teh, LS
    Poulton, K
    RHEUMATOLOGY, 2001, 40 (09) : 1009 - 1012
  • [18] KIKUCHI DISEASE AND ITS ASSOCIATION WITH SYSTEMIC LUPUS-ERYTHEMATOSUS (SLE)
    ELRAMAHI, KM
    KARRAR, A
    ALI, MA
    ARTHRITIS AND RHEUMATISM, 1993, 36 (09): : S276 - S276
  • [19] FcγRIIa and FcγRIIIb polymorphisms and associations with clinical manifestations in systemic lupus erythematosus patients
    Costa Vigato-Ferreira, Isabel Cristina
    Toller-Kawahisa, Juliana Escher
    Tres Pancoto, Joao Alexandre
    Mendes-Junior, Celso Teixeira
    Martinez, Edson Zangiacomi
    Donadi, Eduardo Antonio
    Louzada-Junior, Paulo
    Cavalcanti Del Lama, Jose Eduardo
    Marzocchi-Machado, Cleni Mara
    AUTOIMMUNITY, 2014, 47 (07) : 451 - 458
  • [20] The role of FcγRIIa as an inflammatory mediator in rheumatoid arthritis and systemic lupus erythematosus
    Sardjono, CT
    Mottram, PL
    Hogarth, PM
    IMMUNOLOGY AND CELL BIOLOGY, 2003, 81 (05): : 374 - 381